Skip to main content
Evaluation of Synthetic Oligonucleotides as Inhibitors of West Nile Virus Replication
Antiviral Research
  • P. F. Torrence
  • N. Gupta
  • C. Whitney
  • John D. Morrey, Utah State University
Document Type
Publication Date

A series of synthetic oligonucleotide phosphorothioate 15-mers were generated against specific sequences in the West Nile virus RNA genome. These antisense oligonucleotides targeted (1) conserved features of the West Nile virus RNA genome that may be expected to lead to inhibition of virus replication since such features play essential roles in the virus lifecycle; (2) G-quartet oligonucleotides with potential facilitated uptake properties and that also targeted conserved sequences among a range of West Nile virus strains. Several formulations with significant in vitro antiviral activity were found. Among the active oligonucleotides were examples that targeted both C-rich RNA sequences of the West Nile RNA genome as well as recognized conserved sequences key to West Nile virus replication. Since the antiviral activity of the latter oligonucleotides diminished upon 2′-O-methyl substitution, it is likely that their activity involves RNase H-catalyzed RNA degradation. One G-rich oligonucleotide that did not target a West Nile virus RNA sequence also was found. These results suggest the potential of antisense strategies for the control of West Nile virus replication if the attendant problem of oligonucleotide delivery can be adequately addressed.

Citation Information
Torrence, P.F., N. Gupta, C. Whitney, and J.D. Morrey 2006. Evaluation of synthetic oligonucleotides as inhibitors of west nile virus replication. Antiviral Research, 70(2): 60-65.